Kimberley Nixon
Kimberley Nixon is Founder and Managing Partner at Open Venture Capital (OVC), an early stage venture capital fund. The fund invests in sport, health and wellness brands that have the ability to expand from product to platform via a unique product, marketing and/or community engagement approach. Open Venture Capital began as Open Venture Studio, and for several founders we continue to invest time and resources to build a clear value proposition and a path to scalability before investing capital.
Kimberley is an Operator turned VC. Kim holds deep expertise in leading digital transformations and launching new products to market. Over the course of her 20-year career Kimberley has been entrusted by her clients, boards and executive leadership alike to deliver against key strategic objectives tied to growth optimization and operational excellence. Her work has spanned startup to billion dollar organizations, and across several international markets for companies including Under Armour, Manduka Yoga, Health House, Headspace and Tonal.
Jennifer Simpson
Cristina Rohr
Cristina Rohr a Managing Director of Investments with S2G Ventures. Cristina’s portfolio work ranges from agriculture focused investments in genetics, crop protection, soil health and digital/IOT to consumer facing brands.
Cristina has nearly 10 years of experience in sourcing, executing, managing and exiting venture and private equity investments. Before joining S2G Ventures, Cristina was a private equity investor with the Edgewater Funds in Chicago and, prior to that, with First Reserve in London, where she focused on leveraged buyout investments in the natural resources industry. Cristina also previously worked for Citigroup Investment Banking Division in London.
Cristina graduated from Stanford University with a Bachelor of Arts and Sciences with a double major in Mathematical and Computational Sciences and Economics. She earned her MBA from the University of Chicago’s Booth School of Business.
Patricia Doykos
Patricia “Patti” Mae Doykos is the inaugural executive director for Health Equity at Bristol Myers Squibb. She has responsibility for the company’s $150M Health Equity Commitments as well as a number of domestic and global health partnerships. Embedding a health equity lens in everything BMS does is an opportunity to expand and improve the quality of the company’s science and the reach and impact of its innovative medicines on patients, particularly for medically underserved and increasingly diverse patient populations and journeys.
Patti has over 25 years of experience and leadership in transformative corporate philanthropy and corporate social responsibility, product brand and strategic communications, and health equity and social justice from her roles in the company and the Bristol Myers Squibb Foundation. She has developed and led US and international grant-making and public-private partnership programs for global HIV/AIDS, women’s health, diabetes, cancer, serious mental illness, cardiovascular disease, immunology and COVID19. Among her current service roles are inaugural chair of the board of the Center for Global Health Equity at Dartmouth-Geisel Medical School, Board of Advisors for Dartmouth-Geisel Medical School, Advisory Board for the Center for Global Health at Rutgers University, and Trustee of Phillips Academy Andover and member of its Anti-Racism Task Force.
